Group One Trading, L.P. Aerie Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$6.37 - $15.23 $8,281 - $19,799	1,300 Added 471.01%	1,576 $24,000
Q2 2022 Aug 11, 2022	SELL	$4.95 - $9.16 $4,573 - $8,463	-924 Reduced 77.0%	276 $2,000
Q1 2022 May 12, 2022	BUY	$5.64 - $9.8 $5,076 - $8,820	900 Added 300.0%	1,200 $11,000
Q4 2021 Feb 11, 2022	BUY	$7.02 - $13.33 $2,106 - $3,999	300 New	300 $2,000
Q4 2020 Feb 10, 2021	SELL	$9.12 - $14.49 $383 - $608	-42 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.46 - $14.46 $439 - $607	42 New	42 $0
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $2,904 - $3,903	-242 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$11.84 - $25.52 $22,294 - $48,054	-1,883 Reduced 88.61%	242 $3,000
Q4 2019 Feb 10, 2020	SELL	$17.72 - $25.1 $1.17 Million - $1.65 Million	-65,809 Reduced 96.87%	2,125 $51,000
Q3 2019 Nov 12, 2019	SELL	$18.41 - $28.0 $16,182 - $24,612	-879 Reduced 1.28%	67,934 $1.31 Million
Q2 2019 Aug 09, 2019	BUY	$28.97 - $48.21 $1.99 Million - $3.32 Million	68,813 New	68,813 $2.03 Million
Q4 2017 Feb 09, 2018	SELL	$50.85 - $65.1 $14,288 - $18,293	-281 Closed	0 $0
Q3 2017 Nov 15, 2017	SELL	$48.6 - $60.1 $44,226 - $54,691	-910 Reduced 76.41%	281 $14,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,191	1,191 $63,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.